Sino-nasal rinse delivery device with agitation, flow-control and integrated medication management system

Information

  • Patent Grant
  • 10525240
  • Patent Number
    10,525,240
  • Date Filed
    Tuesday, June 25, 2019
    5 years ago
  • Date Issued
    Tuesday, January 7, 2020
    4 years ago
Abstract
A device, a system and a method are provided to accurately apply a medically beneficial substance directly to a laterally or superiorly located paranasal sinus cavity. When the device is assembled with a solution in a reservoir, and inverted such that the reservoir is above an input apparatus and a housing, weight of the solution pushes down on a diaphragm creating a negative pressure on the diaphragm, which prevents air from entering the reservoir and prevents a liquid from flowing out of the reservoir. Applying a positive pressure to a bottom of the diaphragm causes the diaphragm to open and allows air to flow into the reservoir. When a user creates the positive pressure by exhaling air into the device the act of exhaling causes the user's choana to close. Thereby any solution introduced into the user's sino-nasal cavity will remain contained within the user's sino-nasal cavity increasing effectiveness of treatment and decreasing user discomfort including gagging, choking, and inner ear disturbance. When the positive pressure on the bottom of the diaphragm is removed, the flow of the liquid from the reservoir stops.
Description
TECHNICAL FIELD

Embodiments of the present disclosure relate to nasal and sinus devices. More specifically, embodiments of the disclosure relate to delivering an solution/substance to the nasal and sinus cavities.


BACKGROUND

Paranasal sinuses are cavities formed within the bones of the face that are accessible via an individual's nasal cavity. The paranasal sinuses include the frontal sinuses, the sphenoid sinuses, the ethmoid sinuses, and the maxillary sinuses. Sino-nasal anatomy includes bilateral inferior, middle and supreme turbinate and the midline nasal septum. The paranasal sinuses and nose are lined with mucous-producing respiratory epithelial tissue.


Normally, mucous produced by the linings of the sino-nasal sinuses slowly drains out of each sinus through an opening known as an ostium. Some conditions, however, can interfere with the drainage of the mucous. A healthy sino-nasal condition depends upon proper mucous drainage from the sinus cavities and the nose. When this natural process is disrupted by the effects of allergen, other bioactive particulate matter deposits or abnormal anatomic variations a condition of mucous stasis in the sinus cavities or the nose. As a consequence, nasal lining mucositis and/or sino-nasal disorders (e.g., a sinus infection, sinus headache, epistaxis, nasal obstruction, rhinorrhea) can result. Some of the conventional systemic approaches to treating these disorders often result in cutaneous rash, diarrhea, bacterial resistance from antibiotic use, adrenal suppression, weight gain from steroid medications, hypertension, sleep disturbance from decongestant use, epistaxis, headache, vertigo and others.


Surgery that is performed on the paranasal sinus cavities results in altered, modified or otherwise widened sinus drainage pathways compared to native outflow tracts.


Direct application of a substance to a sinus through a nasal cavity may avoid some of the side-effects listed above that are inherent in a systemic approach to treating sinusitis, rhinitis and/or mucositis.


However, due to the lateral or superior location of sinus outflow tracts the introduction of a substance via a trans-nasal route may result in a large majority of the substance bypassing the intended sinus cavity ostia.


More specifically, the post-surgical maxillary sinus ostia is located on the lateral nasal wall approximately 3.0 to 4.0 centimeters from the apex of the external nasal vestibule and approximately at a 45 degree angle with respect to the floor of the nose. Thus, a substance delivered using a device introduced into the nose at approximately 45 degrees from the floor of the nose with an approximate length of 3 to 4 centimeters and with the capability of directing a substance at an 80 to 90 degree angle relative to the device itself would have the capability of directly delivering a substance to the maxillary sinus cavity when properly oriented.


Additionally, the post-surgical frontal sinus outflow tract is located superiorly in the nasal cavity at approximately 5 to 6 centimeters from the apex of the external nasal vestibule at approximately 75° to 85° relative to the floor of the nose. Thus, a substance delivered using a device introduced into the nose at approximately 45 degrees from the floor of the nose with an approximate length of 3 to 4 centimeters and with the capability of directing a substance at an 80 to 90 degree angle relative to the device itself would have the capability of directly delivering a substance to the frontal sinus cavity when properly oriented.


Accordingly, there is a need for a device, system, and method of treatment that has the capability to quickly and accurately apply a substance directly to a laterally or superiorly located paranasal sinus outflow tract. The present disclosure discusses a device that satisfies such needs, among the others delineated.


Direct application of a substance to an infected sinus through a nasal cavity will avoid some of the side-effects listed above that are inherent in a systemic approach. However, the introduction of a substance via a trans-nasal route may result in a large majority of the substance flowing down the individual's throat, resulting in possible aspiration, coughing and or choking; if the substance enters the oral cavity it also is distasteful, which further exacerbates the unpleasantness. Additionally, if a substance is forcibly introduced into a nasal cavity it is possible to overcome physiologic proximal Eustachian tube resistance resulting in the substance contaminating the middle-ear. The presence of a substance (other than physiologic body-temperature aeration) in the middle-ear may result in aural fullness, otitis effusion, otitis media, hearing loss (possibly permanent), ossicular chain injury, damage to the middle-ear mucosal lining, dizziness/unsteadiness, nystagmus, nausea and others.


Accordingly, there is a need for a device and/or system that has the capability to quickly and accurately apply a substance to a paranasal sinus and/or sino-nasal cavity, prevent the substance applied to a paranasal sinus and/or sino-nasal cavity from flowing down a patient's throat and/or prevent the substance from contaminating the middle-ear cavity. The present disclosure discusses a device that satisfies such needs, among the others delineated.


Agents used in medicated sinus lavage are commonly supplied in capsule or other form; many individuals with dexterity problems are unable to manage the delivery of medication supplied in capsule or other form into sinus irrigation solution.


With respect to solubility of agents administered as a sinus lavage, there exist a category of agents that are immiscible in an aqueous or saline environment therefore presenting a challenge to delivery of a consistent agent concentration.


The use of saline or other sino-nasal irrigation solution delivered in a non-linear, turbulent, or pulsatile manner provides potentially additional cleansing properties over a solution delivered as a constant, uniform stream.


The effective use of gravity-assist sino-nasal lavage can be limited by an inability to control the flow of irrigation solution due to the siphon effect, i.e. a tube used to convey liquid upwards from a reservoir and then flows down to a lower level due to gravity, once the liquid has been forced into the tube and elevated, flow continues unaided and cannot easily be controlled or stopped.


The effective use of gravity-assist sino-nasal lavage can be further limited by an inability to extend the neck and look upwards, as is required in the application of conventional sino-nasal irrigation systems that rely on gravity to dispense the solution. This limitation is particularly acute for persons with neck extension limitations or persons who experience dizziness in this position, in particular elderly persons.


Sino-nasal rinsing can be limited by design features that are selective for specific anatomy, specifically that of adult versus children.


SUMMARY

Embodiments of the disclosure relate to delivering a pharmaceutically acceptable buffer preferably consisting of sterile saline solution or a solution with a therapeutically effective concentration of a pharmaceutical to nasal and sinus cavities. While multiple embodiments are disclosed, still other embodiments of the present disclosure will become apparent to those skilled in the art from the following detailed description, which shows and describes illustrative embodiments of the disclosure. Accordingly, the drawings and detailed description are to be regarded as illustrative in nature and not restrictive.


The sino-nasal irrigation device consists of a reservoir container; a housing with a grinding chamber and nose piece; and an input apparatus with a mouth piece. The reservoir container is intended for holding an solution. The housing has a grinding chamber for crushing capsules, pills, and the like, with an integrated filter separating the grinding chamber and the reservoir container that allows ground material of a predetermined size to pass through the filter and into the reservoir container. The housing also has a nose piece with a nasal tip and an optional nasal tip extension.


When the sino-nasal irrigation device is assembled with a solution in the reservoir container, and inverted such that the reservoir container is above the input apparatus and the housing, the weight of the solution in the reservoir container pushes down on the diaphragm creating a negative pressure on the diaphragm. The weight of the solution on the diaphragm prevents air from entering the reservoir container and thus prevents solution from the reservoir container from flowing out through the nose piece. Applying a positive pressure to the bottom of the diaphragm causes the diaphragm to open and allows air to flow into the reservoir container. The air flowing into the reservoir container causes turbulence in the solution held in the reservoir container resulting in the mixing of the air and solution. The air flowing into the reservoir container also allows the solution in the reservoir container to flow out of the reservoir through the nose piece and into a user's nasal cavity. When the positive pressure on the bottom of the diaphragm is removed, the flow of liquid from the reservoir container stops.





DESCRIPTION OF THE DRAWINGS

The accompanying drawings are incorporated into and form a part of the specification to illustrate several examples of the present disclosure. These drawings, together with the description, explain the principles of the disclosure. The drawings simply illustrate preferred and alternative examples of how the disclosure may be made and used and are not to be construed as limiting the disclosure to only the illustrated and described examples. Further features and advantages will become apparent from the following, more detailed, description of the various aspects, embodiments, and configurations of the disclosure, as illustrated by the drawings referenced below.



FIG. 1 is a perspective view of an illustrative system for delivering an solution to the nasal cavity and or paranasal sinuses of a user, in accordance with the embodiments of the present disclosure.



FIG. 2 is an exploded perspective view of an illustrative system for delivering an solution to the nasal cavity or paranasal sinuses of a user, in accordance with the embodiments of the present disclosure.



FIG. 3a is a top view of the nasal tips 160a to accommodate the customary nasal opening sizes of children, 160b adults generally, and 160c for larger adults.



FIG. 3b is a bottom view of the nasal tips 160a to accommodate the customary nasal opening sizes of children, 160b adults generally, and 160c for larger adults.



FIG. 3c is a sideview of the nasal tips 160a to accommodate the customary nasal opening sizes of children, 160b adults generally, and 160c for larger adults which are generally circular and thus the view from all sides is the same.



FIG. 4 is a bottom view of the input apparatus (170).



FIG. 5a is a top view of the housing (120).



FIG. 5b is a bottom view of the housing (120).



FIG. 6a is a view of the first distal end (205) of the mortar (200).



FIG. 6b is a view of the second distal end (207) of the mortar (200).



FIG. 7 is a cross-sectional view of a patient's head with an embodiment of the system for delivering an solution to the nasal cavity and or paranasal sinuses of a user with a nasal tip (160).



FIG. 8 is a cross-sectional view of a patient's head with an embodiment of the system for delivering an solution to the nasal cavity and or paranasal sinuses of a user with a nasal tip for directional flow (167) adapted to a user's nasal cavity by angling 80° to 90° degrees above the horizontal axis.



FIG. 9 is a cross-sectional view of a patient's head with an embodiment of the system for delivering an solution to the nasal cavity and or paranasal sinuses of a user with a nasal tip for directional flow (167) adapted to a user's nasal cavity by angling 80° to 90° degrees above the horizontal axis.



FIG. 10 is a flow chart detailing a preferred method of using the invention disclosed herein.



FIG. 11 is a perspective view of an alternative embodiment of illustrative system for delivering an solution to the nasal cavity and or paranasal sinuses of a user with a base for heating and mixing the solution, in accordance with the embodiments of the present disclosure.



FIG. 12 is a perspective view of an alternative embodiment of illustrative system for delivering an solution to the nasal cavity and or paranasal sinuses of a user with a base for heating and stirring the solution, in accordance with the embodiments of the present disclosure.



FIG. 13 is a partially exploded perspective view of an alternative embodiment of the illustrative system for delivering an solution to the nasal cavity and or paranasal sinuses of a user with a partial cross-section of the bottom.



FIG. 14 is a prospective view of the base (700).





DETAILED DESCRIPTION

Before any embodiments of the disclosure are explained in detail, it is to be understood that the disclosure is not limited in its application to the details of construction and the arrangement of components set forth in the following description or illustrated in the drawings. The disclosure is capable of other embodiments and of being practiced or of being carried out in various ways. Also, it is to be understood that the phraseology and terminology used herein is for the purpose of description and should not be regarded as limiting.


While the disclosed subject matter is amenable to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings and are described in detail below. The intention, however, is not to limit the disclosure to the particular embodiments described. To the contrary, the disclosure is intended to cover all modifications, equivalents, and alternatives falling within the scope of the disclosure as defined by the appended claims.


The term “solution” as used herein means a liquid; water; a pharmaceutically acceptable buffer solution, preferably consisting of a saline solution and more preferably still a sterile saline solution; and, a solution with a therapeutically effective concentration of a pharmaceutical. The pharmaceutical compound portion of the solution may be a salt, solid, liquid, or a gas (including a vapor). The pharmaceutical compound may be selected form any of the biopharmaceutical classes of the Biopharmaceutical Classification System (BCS) where Class 1 has high permeability and high solubility to Class 4 which has low permeability to low solubility. The solution containing a pharmaceutical compound may be an unsaturated solution, a saturated solution, a supersaturated solution, a mixture of two or more substances that are not chemically combined, a homogenous solution, a heterogenous solution, a suspension, or an emulsion.


The use of “including,” “comprising,” or “having” and variations thereof herein is meant to encompass the items listed thereafter and equivalents thereof as well as additional items.


As the terms are used herein with respect to ranges of measurements (such as those described above), “about” and “approximately” may be used interchangeably, to refer to a measurement that includes the stated measurement and that also includes any measurements that are reasonably close to the stated measurement, but that may differ by a reasonably small amount such as will be understood, and readily ascertained, by individuals having ordinary skill in the relevant arts to be attributable to measurement error, differences in measurement and/or manufacturing equipment calibration, human error in reading and/or setting measurements, adjustments made to optimize performance and/or structural parameters in view of differences in measurements associated with other components, particular implementation scenarios, imprecise adjustment and/or manipulation of objects by a person or machine, and/or the like.


Although the term “block” may be used herein to connote different elements illustratively employed, the term should not be interpreted as implying any requirement of, or particular order among or between, various steps disclosed herein unless and except when explicitly referring to the order of individual steps. Additionally, a “set” or “group” of items (e.g. inputs, algorithms, data values, etc.) may include one or more items, and, similarly, a subset or subgroup of items may include one or more items.


The term “means” as used herein shall be given its broadest possible interpretation in accordance with 35 U.S.C. Section 112(f). Accordingly, a claim incorporating the term “means” shall cover all structures, materials, or acts set forth herein, and all of the equivalents thereof. Further, the structures, materials or acts and the equivalents thereof shall include all those described in the summary of the invention, brief description of the drawings, detailed description, abstract, and claims themselves.


Sino-Nasal Irrigation Device

Referring to FIGS. 1 to 9, the sino-nasal irrigation device (100) consists of a reservoir container (110), a housing (120) that is removably connected to the reservoir container (110) having a grinding chamber (125), a nose tube (150), and an input device (170) that is removably connected to the housing (120).


The reservoir container (110) in the preferred embodiment has a hollow interior cavity adapted to contain an solution and has a base (112). The reservoir container (110) has a curved sidewall (115) that extends substantially perpendicular to the base (112) to the open top (117) of the reservoir container (110) thereby defining the hollow interior cavity. The reservoir container (110) is adapted to removably engage the housing (120). In the preferred embodiment the reservoir container (110) has male threads (118) to threadingly mate with the housing (120). The reservoir container (110) may be of any shape or size including a round bulbous shape, a square or a rectangle.


The housing (120) is removable attachable to the reservoir container (110). In the preferred embodiment the housing (120) has female threads (124) to threadably mate with the reservoir container (110). The top of the housing (122) has a grinding chamber (125) and a nose piece aperture (140). The grinding chamber (125) has a sidewall (128) that is preferably curved and extending substantially perpendicular to the top of the housing (122). The grinding chamber (125) has a filter (135) at the base that is integrated into the housing top (122) consisting of a plurality of holes (138) that will allow ground material of a defined size and water or a solution to pass through the filter (135). The plurality of holes (138) may be of uniform size or varying size. In the preferred embodiment the plurality of holes (138) are of varying size ranging from ⅛th of an inch in diameter to 3/16th of an inch in diameter.


In an alternative preferred embodiment other substances including powders, liquids, gaseous and vapors may be introduced into the reservoir container (110) through the filter integrated into the grinding chamber (135) or by bypassing the grinding chamber (125) and introduced directly into the solution in the reservoir container (110). In an alternative preferred embodiment a vapor pod (not shown) may be removably attached to the air tube (180) so that when a user exhales into the mouth piece (185) on the input apparatus (170) air and vapor from the vapor pod creates a positive pressure in the air tube (180) and air and vapor passes through the diaphragm (190) and into the reservoir container (110) where the vapor mixes with and dissolves into the solution. The introduction of air and vapor into the reservoir container (110) displacing the solution held in the reservoir container (110) out the nose tube (150) through the nasal tip (160).


The grinding chamber (125) also has a plurality of grinding teeth (130) that extend substantially perpendicular to the filter (135). The plurality of grinding teeth (130) may be of either uniform size and shape or varied size and shape. In the preferred embodiment the plurality of grinding teeth (130) consist of a plurality of cured grinding teeth (131) spaced equal distantly in a circular pattern in the grinding chamber (125) and a plurality of wedge shaped grinding teeth (132) located within the circular pattern formed by the curved grinding teeth (131).


The nose tube (150) is attached to the nose piece aperture (140) in the housing top (122). In the preferred embodiment the nose piece aperture (140) is a curve-linear oval shape. The nose tube (150) is preferably substantially rigid and curved such that when the sino-nasal device (100) is inverted the mouth piece (185) is proximate a user's mouth then the distal end of the nose tube (150) is proximate a user's nose bench. The nose tube (150) has a removable nasal tip (160) at the distal end of the nose tube (150). The nasal tip (160) frictionally engages the nose tube (150) and thus is adjustable and may be positioned in a preferable location for each user. The nasal tip (160) may be removed from the nose tube (150) for cleaning or replacement. The nasal tip (160) has various sizes and shapes (160a-160c) to accommodate the customary nasal opening sizes of children (160a), adults (160b), and larger adults (160c).


An alternative preferred embodiment may include a nasal tip for directional flow (167) that frictionally engage the nose tube (150) or the nasal tip aperture opening (165) to provide for a more controlled and direction application of medicine and/or solution to a surgical site, wound, or by user preference. The nasal tip for directional flow (167) is preferably flexible with a blunt terminal end (168) with a plurality of aperture openings (169) proximate to the terminal end that are preferably 2 to 4 mm in length and more preferably 1 to 2 mm in length. The plurality of aperture openings (169) are preferably oval, but may also be substantially circular or substantially square in order to provide a desired flow rate of solution in a preferred direction. The nasal tip for directional flow (167) are preferably 1 to 4 cm length, and more preferably 1 to 2 cm length. The exposed length of nasal tip for directional flow (167) may also be controlled by how far the nasal tip for directional flow (167) is inserted on the nose tube (150), or alternatively, into the tip aperture opening (165) in order to maximize the delivery of medicine and/or solution to a surgical site, wound, or by preference of a user.


The input apparatus (170) is removably attached to the grinding chamber (125) on the housing (120). In the preferred embodiment the input apparatus (170) has a hollow interior cavity (177) that is threaded to connect to the exterior of the grinding chamber sidewall (128). When the input apparatus (170) is attached to the grinding chamber (125) the mouth piece (185) of the input device (170) should align with the nasal tip (160) of the housing (120) when assembled and closed. The input apparatus (170) is comprised of a mouth piece (185) that is frictionally attached to an air tube (180) so that the location of the mouth piece (185) may be configured in a preferred way for each user. The air tube (180) is also connected to the L-connector (175) of the input apparatus (170). In the preferred embodiment the air tube (180) connects in the center of the top of the L-connector (175) which is attached to the input apparatus (170). A diaphragm (190) is interposed at the terminal end of the air tube (180) where the air tube (180) connects to the input apparatus (170).


When the sino-nasal irrigation device is assembled with a solution in the reservoir container, the diaphragm (190) permits air into the reservoir container (110) when a positive pressure exists in the air tube (180) by allowing air to pass through the diaphragm (190). When a positive pressure does not exist in the air tube (180), then the diaphragm (190) prevents the flow of an solution in the reservoir container (110) from flowing pass the diaphragm (190) and out the input apparatus (170).


The mortar (200) has a first distal end (205) with a recess (210) containing a plurality of grinding teeth (205) and a second distal end (207) with a plurality of tines (prongs) (225) that are covered by a frictionally engaged cap (220). In the preferred embodiment the plurality of grinding teeth (215) in the recess (210) in the first distal end (205) consist of a plurality of curved grinding teeth (215) spaced equal distantly in a circular pattern in the recess (210) and a square pike grinding tooth (210) in the center of the recess (210). The second distal end (207) has a plurality of tines (225) that may be sized or of variable sizes. In the preferred embodiment, the size and placement of the tines (225) matches the aperture size and pattern of the plurality of holes (138) in the filter integrated into the bottom of the grinding chamber (135) to facility the cleaning of the grinding chamber (135) by dislodging any material caught in the integrated filter (135) by pushing the tines (225) into underside of the integrated filter (135) in the housing top (122).


Referring to FIGS. 11 to 14, in an alternative preferred embodiment the reservoir container (610) has a hollow interior cavity adapted to contain an solution and has a threaded base cap (615) to be removably connected to the reservoir container (610). The threaded base cap (615) can withstand direct radiant heating in the range of 75° F. to 150° F. and more preferably 80° F. to 110° F. without any chemical breakdown or leaching of the chemicals used to make the reservoir container (610) or threaded base cap (615). The threaded base cap (615) has a flexible barrier layer (630) that permits a temperature probe (730) from the base station (700) to extend into the reservoir container (610) without coining in direct contact with the solution in the reservoir container (610). The reservoir container (110) has a curved sidewall (115) that extends substantially perpendicular to the base (112) to the open top (117) of the reservoir container (110) thereby defining the hollow interior cavity.


The base station (700) contains a logic engine that permits a user to input the desired temperature a user wants the solution in the reservoir container (610) warmed to. The temperature probe (730) takes a temperature reading, and then compares that temperature reading to the input temperature. If the temperature reading is below the input temperature, then the logic engine provides power to the base station heating sources (720) in order to raise the temperature of the solution to the input temperature. Once the solution reaches the input temperature, the logic engine may reduce power to the base station heating source (720) or turn the base station heating source off. The logic engine will continue to measure the temperature of the solution through the temperature probe (730) and apply heat as needed to maintain temperature. The temperature probe (730) is preferably a thermistor, thermocouple or similar temperature measuring probe. The base station heating source (720) is preferably resistive heating coils but may be any known heating source known to one of ordinary skill in the art.


The alternative preferred embodiment may also have indirect stirring means such as a magnetic stirrer consisting of one or more magnets in the base station and at least one magnet in the reservoir container that may be used to stir the solution to aid the dissolution of difficult to dissolve chemical compounds into solution.


The alternative preferred embodiment may also include an ultra-violate (UV) light source proximately located adjacent to the reservoir container (610) that will sterilize the water in the reservoir container (610).


Method of Using the Sino-Nasal Irrigation Device

The sino-nasal irrigation device (100) may be used by filling the reservoir container (110) with the desired amount of water. Preferably, and recommended, sterile water is used. Alternatively, denatured water may be used. The housing (120) is then removably engaged on the reservoir container (110).


Optionally, if a user wants to use an aqueous saline solution, then the user may place capsule(s) containing the equivalent of 2.4 grains of sodium chloride (NaCl) per 10 ounces of water into the grinding chamber (125) on the housing (120). Then, while firming holding the reservoir container (110), the user engages the first distal end (205) of the mortar (200) with the grinding chamber (125) containing the capsule to grind the capsule and its contents to sufficiently fine size to pass through the filter integrated into the bottom of the grinding chamber (135). Preferably, grinding of a capsule is achieved by twisting the mortar (200) in the grinding chamber (125) while applying downward pressure. Thereby allowing the ground capsule to form an solution in reservoir container (110). If the plurality of holes (138) in the filter (135) have become occluded with remnants of the capsule, then the plurality of holes (138) should be cleared by removing the housing (120) from the reservoir container (110) and pushing the tines (225) on the second distal end of the mortar (207) through plurality of holes from the underside of the integrated filer (135) in the housing top (122) to dislodge any material occluding the filter holes (135). The housing (120) is then removably engaged on the reservoir container (110). In an alternative preferred embodiment other substances including powders, liquids, gaseous and vapors may be introduced into the reservoir container (110) through the filter integrated into the grinding chamber (135) or by bypassing the grinding chamber (125) and directly into the substance into the reservoir container (110), thereby creating an solution.


The input apparatus (170) may then be removably engaged on the housing (120). The mouth piece (185) of the input apparatus (170) is aligned with the nasal tip (160) on the housing (120). The sino-nasal irrigation device (100) is then ready for treatment application.


The sino-nasal irrigation device (100) is then inverted such that the reservoir container (110) is above the input apparatus (170) and the housing (120), the weight of the solution in the reservoir container (110) pushes down on the diaphragm (190) creating a negative pressure on the diaphragm (190). The weight of the solution on the diaphragm (190) prevents air from entering the reservoir container (110) and thus prevents liquid from the reservoir container (110) from flowing out through the nose tube (150). Applying a positive pressure to the bottom of the diaphragm (190) causes the diaphragm to open and allows air to flow into the reservoir container (110). The air flowing into the reservoir container (110) causes turbulence in the solution held in the reservoir container resulting in the mixing of the air and solution. The air flowing into the reservoir container also allows the liquid in the reservoir container (110) to flow out of the reservoir (110) through the nose tube (150) and into a user's nasal cavity. When the positive pressure on the bottom of the diaphragm (190) is removed, the flow of liquid from the reservoir container (110) stops.


When a user, blows or exhales against resistance, the user's soft palate/uvula elevates and contacts the posterior wall of the oro/nasopharynx, thereby closing the choana. This normal physiologic process effectively creates temporary anatomic isolation of the nasal cavity from the oral cavity, distal airway and glottis/proximal trachea. As such, any fluid that is introduced into the user's sino-nasal cavity, as described herein, will remain contained within a user's sino-nasal cavity, being directed out the contralateral sino-nasal cavity, and not travel into the user's distal airway, glottis/superior trachea.


In an alternative preferred embodiment, a user blows or exhales against resistance to close the choana by blowing into the mouth piece (185) on the input apparatus (170), but the tube (180) is partially constrained allowing only a fraction of the air exhaled by the user to reach the reservoir container (110), or is fully constrained such that none of the air exhaled by the user reaches the reservoir container (110). When a positive pressure is detected in the tube (180) due to a user exhaling then a small pump (not shown) is activated to pump solution from the reservoir container (110) out the nose tube (150). When the positive pressure is removed, the pump is deactivated and the flow ceases. This alternative preferred embodiment may be used by those with compromised respiratory systems due to illness or other infirmity.


Referring to FIG. 10, a method for using the preferred embodiment is provided for treating a patient (700). Block 710 provides for adding a prescribed amount of sterile, or purified, water to the reservoir container (110). Block 720 provides for the partial assembly of the sino-nasal irrigation device by removably connecting the housing (120) to the reservoir container (110). Block 730 grinding of a capsule, tablet, or the like in the grinding chamber (125) to form a powder fine enough to pass through the filter (135). Block 740 provides for the forming of a solution by allowing the ground powder from the capsule, tablet, or the like to pass through the filter (135) and into the reservoir container (110) where the powder will be dissolved into the liquid to form a solution. Block 750 provides for the further assembly of the sino-nasal irrigation device by removably connecting the input apparatus (170) to the previously assembled reservoir container (110) and housing (120). Block 760 provides for the administration of the solution to a user by inverting the assembled sino-nasal irrigation device (100) so that the reservoir container (110) is above the housing (120) and input apparatus (170) such that any air remaining in the reservoir container (110) is proximate the base of the reservoir container (112), inserting the nasal tip (16) into a nostril of the user, and keeping the nasal tip inserted into a nostril of the user, blowing into the mouth piece (185) to provide a positive pressure in the air tube (180). The positive pressure in the air tube (180) causes air to pass through the diaphragm (190) and into the reservoir container (110) thereby displacing the solution held in the reservoir container (110) out the nose tube (150) through the nasal tip (160).


The foregoing discussion has been presented for purposes of illustration and description. The foregoing is not intended to limit the disclosure to the form or forms disclosed herein. In the foregoing Summary for example, various features of the disclosure are grouped together in one or more aspects, embodiments, and/or configurations for the purpose of streamlining the disclosure. The features of the aspects, embodiments, and/or configurations of the disclosure may be combined in alternate aspects, embodiments, and/or configurations other than those discussed above. For example, the device(s) described in the present) disclosure may be used in conjunction with other medical devices. This method of disclosure is not to be interpreted as reflecting an intention that the claims require more features than are expressly recited in each claim. Rather, as the following claims reflect, inventive aspects lie in less than all features of a single foregoing disclosed aspect, embodiment, and/or configuration. Thus, the following claims are hereby incorporated into this Detailed Description, which each claim standing on its own as a separate preferred embodiment of the disclosure.


Moreover, though the general description of the invention has included detailed description of one or more aspects, embodiments, and/or configurations and certain variations and modifications, other variations, combinations, and modifications are within the scope of this disclosure, e.g., as may be within the skill and knowledge of those in the art, after understanding the present disclosure. The intent is to obtain rights which include alternative aspects, embodiments, and/or configurations to the extent permitted, including alternate, inter-changeable and/or equivalent structures, functions, ranges or steps are disclosed herein, and without intending to publicly dedicate any patentable subject matter.

Claims
  • 1. A device for delivering a solution to a sino-nasal cavity of a user, the device comprising: a reservoir container;a housing adapted to connect to the reservoir container wherein the housing has a nose tube and a grinding chamber with a filter in the housing and a plurality of grinding teeth extending perpendicular to the filter;an input apparatus adapted to connect to the housing wherein the input apparatus has a mouth piece connected to a tube and the tube is connected to a L-connector of the input apparatus; and,a mortar with a first end and a second end.
  • 2. The device for delivering the solution to the sino-nasal cavity of the user of claim 1 wherein the mouth piece is removably attached to a first terminal end of the tube and a diaphragm is interposed at the L-connector of the input apparatus.
  • 3. The device for delivering the solution to the sino-nasal cavity of the user of claim 1 wherein the mortar has the first end with a recess containing a plurality of grinding teeth and the second end with a plurality of tines configured to align with a plurality of holes in the filter.
  • 4. The device for delivering the solution to the sino-nasal cavity of the user of claim 3 wherein the mortar further comprises a removable cap that frictionally engages the mortar and covers the tines of the second end of the mortar.
  • 5. The device for delivering the solution to the sino-nasal cavity of the user of claim 1 further comprising a tip with directional flow that is removably attached to a distal end of the nose tube.
  • 6. A device for delivering a solution to a sino-nasal cavity of a user, the device comprising: a reservoir container adapted to removably engage a housing wherein the housing has a nose piece with a nasal tip adapted to removably attach to a terminal end of the nose piece;an input apparatus with a tube that connects a mouth piece to a L-connector of the input apparatus wherein the mouth piece is adapted to removably connect to the housing; anda mortar with a first end with a plurality of grinding teeth and a second end with a plurality of tines.
  • 7. The device for delivering the solution to the sino-nasal cavity of the user of claim 6 wherein the tube has a first terminal end with the mouth piece removably attached and the L-connector of the input apparatus with a diaphragm interposed between the L-connector and a bottom of the input apparatus.
  • 8. The device for delivering the solution to the sino-nasal cavity of the user of claim 7 wherein the diaphragm permits air flow into the reservoir container when a positive pressure exists in the tube.
  • 9. The device for delivering the solution to the sino-nasal cavity of the user of claim 7 wherein the diaphragm prevents gravity flow of the solution from the reservoir container when a positive pressure does not exist in the tube.
  • 10. The device for delivering the solution to the sino-nasal cavity of the user of claim 7 wherein the plurality of tines of the second end of the mortar are configured to match a plurality of holes in a filter.
  • 11. The device for delivering the solution to the sino-nasal cavity of the user of claim 6 further comprising a nasal tip extension with directional flow adapted to removably engage the terminal end of the nose piece or the nasal tip.
  • 12. The device for delivering the solution to the sino-nasal cavity of the user of claim 6 wherein the housing has a grinding chamber with a filter comprising a plurality of holes in the housing.
  • 13. The device for delivering the solution to the sino-nasal cavity of the user of claim 6 wherein the nasal tip is selected from the group consisting of: a nasal tip to accommodate nasal opening sizes of children; a nasal tip to accommodate nasal opening sizes of adults; and, a nasal tip to accommodate nasal opening sizes of larger adults.
  • 14. A device for delivering a solution to a sino-nasal cavity of a user, the device comprising: a reservoir container adapted to removably engage a housing wherein the housing has a nose piece with a nasal tip adapted to removably attach to a terminal end of the nose piece;the housing further comprising a grinding chamber with a filter in the housing consisting of a plurality of holes in the housing and a plurality of grinding teeth extending perpendicular to the filter; and,an input apparatus with a tube with a mouth piece at a first terminal end of the tube and a diaphragm at a second terminal end of the tube that connects to a L-connector of the input apparatus.
  • 15. The device for delivering the solution to the sino-nasal cavity of the user of claim 14 wherein the diaphragm has a first closed position that prevents gravity flow of the solution in the reservoir container when a positive pressure does not exist in the tube and a second open position that permits air flow into the reservoir container when the positive pressure exists in the tube.
  • 16. The device for delivering the solution to the sino-nasal cavity of the user of claim 14 further comprising a nasal tip extension with directional flow adapted to removably engage the terminal end of the nose piece or the nasal tip.
  • 17. The device for delivering the solution to the sino-nasal cavity of the user of claim 14 further comprising a mortar with a first terminal end with a plurality of grinding teeth and a second terminal end with a plurality of tines.
  • 18. The device for delivering the solution to the sino-nasal cavity of the user of claim 17 wherein the plurality of tines of the second terminal end of the mortar are configured to match the plurality of holes of the filter.
CROSS REFERENCE TO RELATED APPLICATION

The present application claims the benefit of and priority to, under 35 U.S.C. § 119(e), U.S. Provisional Application Ser. No. 62/691,010 filed on Jun. 28, 2018 entitled “Sino-Nasal Rinse Delivery Device with Agitation, Flow-Control and Integrated Medication Management System”; U.S. Provisional Application Ser. No. 62/782,889 filed on Dec. 20, 2018 entitled “Sino-Nasal Apparatus and Delivery Method Using Choanal Blockade and Electronic Agent Vaporization”; and, U.S. Provisional Application Ser. No. 62/782,898 filed on Dec. 20, 2018 entitled “Eustachian Tube Dysfunction Treatment Method with Isolating, Incremental, Auto-Insufflation Pressure Generator”, which are hereby incorporated herein by reference in their entireties for all that they teach and for all purposes.

US Referenced Citations (563)
Number Name Date Kind
2434875 Turnbull et al. Jan 1948 A
2493326 Trinder Jan 1950 A
2847997 Tibone Aug 1958 A
2936760 Gants May 1960 A
3049125 Kriwkowitsch Aug 1962 A
3664330 Deutsch May 1972 A
3747595 Grossan Jul 1973 A
3766924 Pidgeon Oct 1973 A
3800788 White Apr 1974 A
3850176 Gottschalk Nov 1974 A
3903893 Scheer Sep 1975 A
4592357 Ersek Jun 1986 A
4606346 Berg et al. Aug 1986 A
4819619 Augustine et al. Apr 1989 A
4883465 Brennan Nov 1989 A
4886493 Yee Dec 1989 A
4887593 Wiley et al. Dec 1989 A
5024658 Kozlov et al. Jun 1991 A
5116311 Lofstedt May 1992 A
5189727 Guerreri Feb 1993 A
5193525 Silverstein et al. Mar 1993 A
5213115 Zytkovicz et al. May 1993 A
5215536 Lampropoulos et al. Jun 1993 A
5242400 Blake et al. Sep 1993 A
5370640 Kolff Dec 1994 A
5446070 Mantelle Aug 1995 A
5462553 Dolgin Oct 1995 A
5483951 Frassica et al. Jan 1996 A
5514128 Hillsman et al. May 1996 A
5531676 Edwards et al. Jul 1996 A
5534242 Henry Jul 1996 A
5546964 Stangerup Aug 1996 A
5599304 Shaari Feb 1997 A
5626553 Frassica et al. May 1997 A
5647847 Lafontaine et al. Jul 1997 A
5667476 Frassica et al. Sep 1997 A
5676635 Levin Oct 1997 A
5685822 Harhen Nov 1997 A
5718666 Alarcon Feb 1998 A
5735817 Shantha Apr 1998 A
5752971 Rosenbluth et al. May 1998 A
5792100 Shantha Aug 1998 A
5819727 Linder Oct 1998 A
5827177 Oneda et al. Oct 1998 A
5827224 Shippert Oct 1998 A
5858331 Henry Jan 1999 A
5876329 Harhen Mar 1999 A
6027478 Katz Feb 2000 A
6106496 Arnissolle Aug 2000 A
6174280 Oneda et al. Jan 2001 B1
6190330 Harhen Feb 2001 B1
6258101 Blake et al. Jul 2001 B1
6322542 Nilson et al. Nov 2001 B1
6350231 Ailinger et al. Feb 2002 B1
6350465 Jonnalagadda et al. Feb 2002 B1
6394093 Lethi May 2002 B1
6413499 Clay Jul 2002 B1
6432986 Levin Aug 2002 B2
6461294 Oneda et al. Oct 2002 B1
6491940 Levin Dec 2002 B1
6529756 Phan et al. Mar 2003 B1
6530881 Ailinger et al. Mar 2003 B1
6579582 Harhen et al. Jun 2003 B1
D478987 Groenke et al. Aug 2003 S
6607546 Murken Aug 2003 B1
6669711 Noda Dec 2003 B1
6677321 Levin Jan 2004 B1
6693670 Stark Feb 2004 B1
6715485 Djupesland Apr 2004 B1
6733440 Ailinger et al. May 2004 B2
6740030 Martone et al. May 2004 B2
6758840 Knox Jul 2004 B2
6770080 Kaplan et al. Aug 2004 B2
6793661 Hamilton et al. Sep 2004 B2
6822213 Stark Nov 2004 B2
6853858 Shalev Feb 2005 B2
6902535 Eberhart et al. Jun 2005 B2
7025923 Harhen et al. Apr 2006 B2
7056284 Martone et al. Jun 2006 B2
7056287 Taylor et al. Jun 2006 B2
7081097 Martone et al. Jul 2006 B2
7112578 Levin Sep 2006 B2
D530815 Murphy et al. Oct 2006 S
7117033 Shalev et al. Oct 2006 B2
7120489 Shalev et al. Oct 2006 B2
7131969 Hovda et al. Nov 2006 B1
D534216 Makower et al. Dec 2006 S
7146209 Gross et al. Dec 2006 B2
7169161 Bonnette et al. Jan 2007 B2
7190998 Shalev et al. Mar 2007 B2
D544602 Hughett et al. Jun 2007 S
7336309 Stark Feb 2008 B2
7361168 Makower et al. Apr 2008 B2
7377901 Djupesland et al. May 2008 B2
7410480 Muni et al. Aug 2008 B2
7419497 Muni et al. Sep 2008 B2
7462175 Chang et al. Dec 2008 B2
7500971 Chang et al. Mar 2009 B2
7507200 Okada Mar 2009 B2
7520876 Ressemann et al. Apr 2009 B2
7559925 Goldfarb et al. Jul 2009 B2
7561919 Shalev et al. Jul 2009 B2
7636597 Gross et al. Dec 2009 B2
7640062 Shalev Dec 2009 B2
7641644 Chang et al. Jan 2010 B2
7642563 Kang et al. Jan 2010 B2
7645272 Chang et al. Jan 2010 B2
7648367 Makower et al. Jan 2010 B1
7654997 Makower et al. Feb 2010 B2
7678099 Ressemann et al. Mar 2010 B2
7684859 Shalev et al. Mar 2010 B2
7704259 Kaplan et al. Apr 2010 B2
7717933 Becker May 2010 B2
7720521 Chang et al. May 2010 B2
7727186 Makower et al. Jun 2010 B2
7727226 Chang et al. Jun 2010 B2
7729759 Shalev et al. Jun 2010 B2
7740642 Becker Jun 2010 B2
7749515 Blumenfeld Jul 2010 B2
7753929 Becker Jul 2010 B2
7753930 Becker Jul 2010 B2
7771409 Chang et al. Aug 2010 B2
7785315 Muni et al. Aug 2010 B1
7799337 Levin Sep 2010 B2
7803150 Chang et al. Sep 2010 B2
7837672 Intoccia Nov 2010 B2
7841337 Djupesland Nov 2010 B2
7842062 Keith et al. Nov 2010 B2
7854744 Becker Dec 2010 B2
7877147 Shalev et al. Jan 2011 B2
7879011 Chang Feb 2011 B2
7879061 Keith et al. Feb 2011 B2
7908000 Shalev Mar 2011 B2
7918871 Truitt et al. Apr 2011 B2
D640374 Liu et al. Jun 2011 S
D643115 Gonzales et al. Aug 2011 S
8010189 Shalev Aug 2011 B2
8012084 Machida Sep 2011 B2
8025635 Eaton et al. Sep 2011 B2
8052693 Shahoian Nov 2011 B2
8080000 Makower et al. Dec 2011 B2
8088101 Chang et al. Jan 2012 B2
8090433 Makower et al. Jan 2012 B2
8100933 Becker Jan 2012 B2
8114062 Muni et al. Feb 2012 B2
8114113 Becker Feb 2012 B2
8118757 Morriss Feb 2012 B2
8123722 Chang et al. Feb 2012 B2
8142422 Makower et al. Mar 2012 B2
D658291 Jenkins et al. Apr 2012 S
8146400 Goldfarb et al. Apr 2012 B2
8172828 Chang et al. May 2012 B2
8182432 Kim et al. May 2012 B2
8190389 Kim et al. May 2012 B2
8192420 Morriss et al. Jun 2012 B2
8224438 Levin Jul 2012 B2
8229571 Lorian et al. Jul 2012 B2
8231588 Xia Jul 2012 B2
8241266 Keith et al. Aug 2012 B2
8241641 Blumenfeld Aug 2012 B2
8249700 Clifford et al. Aug 2012 B2
8277478 Drontle et al. Oct 2012 B2
8282667 Drontle et al. Oct 2012 B2
8308709 Chang Nov 2012 B2
8313520 Barbut et al. Nov 2012 B2
8317816 Becker Nov 2012 B2
8337454 Eaton et al. Dec 2012 B2
8348969 Keith et al. Jan 2013 B2
8360968 Hadani Jan 2013 B2
8388600 Eldredge Mar 2013 B1
8388642 Muni et al. Mar 2013 B2
8412336 Pless et al. Apr 2013 B2
8414473 Jenkins et al. Apr 2013 B2
8425457 John et al. Apr 2013 B2
8425488 Clifford et al. Apr 2013 B2
8435290 Clifford et al. May 2013 B2
8439687 Morriss et al. May 2013 B1
8452392 Morriss et al. May 2013 B2
D683852 Gonzales et al. Jun 2013 S
8480658 Nakao Jul 2013 B1
8485199 Morriss Jul 2013 B2
8486155 McAlister et al. Jul 2013 B2
8550073 Djupesland Oct 2013 B2
8568439 Keith et al. Oct 2013 B2
8585728 Keith et al. Nov 2013 B2
8585729 Keith et al. Nov 2013 B2
8623043 Keith et al. Jan 2014 B1
8636684 Deem et al. Jan 2014 B2
8657846 Keith et al. Feb 2014 B2
8690839 Xia et al. Apr 2014 B2
8702626 Kim et al. Apr 2014 B1
8715169 Chang et al. May 2014 B2
8721591 Chang et al. May 2014 B2
8740839 Eaton et al. Jun 2014 B2
8740929 Gopferich et al. Jun 2014 B2
8747389 Goldfarb et al. Jun 2014 B2
8764709 Chang et al. Jul 2014 B2
8764726 Chang et al. Jul 2014 B2
8764729 Muni et al. Jul 2014 B2
8764786 Becker Jul 2014 B2
8777926 Chang et al. Jul 2014 B2
8801670 Drontle et al. Aug 2014 B2
8828041 Chang et al. Sep 2014 B2
8834513 Hanson et al. Sep 2014 B2
8852143 Chang et al. Oct 2014 B2
8858551 Naito Oct 2014 B2
8858586 Chang et al. Oct 2014 B2
8858974 Eaton et al. Oct 2014 B2
8864787 Muni et al. Oct 2014 B2
8876794 Xia Nov 2014 B2
8882795 Drontle et al. Nov 2014 B2
8888686 Drontle et al. Nov 2014 B2
8894614 Muni et al. Nov 2014 B2
8905922 Makower et al. Dec 2014 B2
8905980 Xia Dec 2014 B2
8910629 Djupesland et al. Dec 2014 B2
8915938 Keith et al. Dec 2014 B2
8932276 Morriss et al. Jan 2015 B1
8954149 Shalev Feb 2015 B2
8956280 Eversull et al. Feb 2015 B2
8961398 Makower et al. Feb 2015 B2
8978647 Djupesland et al. Mar 2015 B2
8986340 Drontle et al. Mar 2015 B2
9010325 Djupesland et al. Apr 2015 B2
D730515 Shahidi Bonjar May 2015 S
9038630 Djupesland et al. May 2015 B2
D735848 Dubuc et al. Aug 2015 S
D736922 Allen et al. Aug 2015 S
9248266 Chandler et al. Feb 2016 B2
D772406 Sanso et al. Nov 2016 S
D773644 Djupesland Dec 2016 S
9510743 Chandler et al. Dec 2016 B2
9516995 Chandler et al. Dec 2016 B2
9649456 Djupesland et al. May 2017 B2
9694163 Chandler et al. Jul 2017 B2
9757455 Roberts et al. Sep 2017 B2
9839347 Chandler et al. Dec 2017 B2
10112021 Hafner Oct 2018 B2
20010002999 Neuser et al. Jun 2001 A1
20010004644 Levin Jun 2001 A1
20020010194 Levin Jan 2002 A1
20020062119 Zadno-Azizi May 2002 A1
20020161379 Kaplan et al. Oct 2002 A1
20030120256 Lary et al. Jun 2003 A1
20030133877 Levin Jul 2003 A1
20030208249 Chen Nov 2003 A1
20040064150 Becker Apr 2004 A1
20040116958 Gopferich et al. Jun 2004 A1
20040243172 Hogle Dec 2004 A1
20050072430 Djupesland Apr 2005 A1
20050080357 Eberhart et al. Apr 2005 A1
20050113798 Slater et al. May 2005 A1
20050124856 Fujikura et al. Jun 2005 A1
20050228452 Mourlas et al. Oct 2005 A1
20050240147 Makower et al. Oct 2005 A1
20050245894 Zadno-Azizi Nov 2005 A1
20050245906 Makower et al. Nov 2005 A1
20050281751 Levin Dec 2005 A1
20060004286 Chang et al. Jan 2006 A1
20060004323 Chang et al. Jan 2006 A1
20060063973 Makower et al. Mar 2006 A1
20060095066 Chang et al. May 2006 A1
20060106361 Muni et al. May 2006 A1
20060155304 Kaplan et al. Jul 2006 A1
20060161044 Oneda et al. Jul 2006 A1
20060167439 Kalser et al. Jul 2006 A1
20060189844 Tien Aug 2006 A1
20060189847 Yee et al. Aug 2006 A1
20060210605 Chang et al. Sep 2006 A1
20070015964 Eversull et al. Jan 2007 A1
20070020254 Levin Jan 2007 A1
20070043327 Knox Feb 2007 A1
20070073269 Becker Mar 2007 A1
20070112257 Hensler May 2007 A1
20070119451 Wang et al. May 2007 A1
20070129705 Trombley et al. Jun 2007 A1
20070129751 Muni et al. Jun 2007 A1
20070135789 Chang et al. Jun 2007 A1
20070142709 Martone et al. Jun 2007 A1
20070167682 Goldfarb et al. Jul 2007 A1
20070179518 Becker Aug 2007 A1
20070208252 Makower Sep 2007 A1
20070208301 Evard et al. Sep 2007 A1
20070249896 Goldfarb et al. Oct 2007 A1
20070250105 Ressemann et al. Oct 2007 A1
20070260264 Nobis et al. Nov 2007 A1
20070265618 Long Nov 2007 A1
20070267011 Deem et al. Nov 2007 A1
20070282305 Goldfarb et al. Dec 2007 A1
20070293726 Goldfarb et al. Dec 2007 A1
20070293727 Goldfarb et al. Dec 2007 A1
20070293946 Gonzales et al. Dec 2007 A1
20080004613 Barbut et al. Jan 2008 A1
20080015472 Ressemann et al. Jan 2008 A1
20080015540 Muni et al. Jan 2008 A1
20080082045 Goldfarb et al. Apr 2008 A1
20080097154 Makower et al. Apr 2008 A1
20080097239 Chang et al. Apr 2008 A1
20080097295 Makower et al. Apr 2008 A1
20080097400 Chang et al. Apr 2008 A1
20080097514 Chang et al. Apr 2008 A1
20080097515 Chang et al. Apr 2008 A1
20080097516 Chang et al. Apr 2008 A1
20080103361 Makower et al. May 2008 A1
20080103521 Makower et al. May 2008 A1
20080119693 Makower et al. May 2008 A1
20080125626 Chang et al. May 2008 A1
20080125720 Kim et al. May 2008 A1
20080132938 Chang et al. Jun 2008 A1
20080154237 Chang et al. Jun 2008 A1
20080154250 Makower et al. Jun 2008 A1
20080172033 Keith et al. Jul 2008 A1
20080183128 Morriss et al. Jul 2008 A1
20080195041 Goldfarb et al. Aug 2008 A1
20080208242 Becker Aug 2008 A1
20080208243 Becker Aug 2008 A1
20080215082 Becker Sep 2008 A1
20080215083 Becker Sep 2008 A1
20080228085 Jenkins et al. Sep 2008 A1
20080234720 Chang et al. Sep 2008 A1
20080243140 Gopferich et al. Oct 2008 A1
20080262468 Clifford et al. Oct 2008 A1
20080262505 Shahoian Oct 2008 A1
20080262508 Clifford et al. Oct 2008 A1
20080262509 Clifford et al. Oct 2008 A1
20080262510 Clifford Oct 2008 A1
20080269643 Morriss Oct 2008 A1
20080275483 Makower et al. Nov 2008 A1
20080279895 Blumenfeld Nov 2008 A1
20080281156 Makower et al. Nov 2008 A1
20080281300 Morriss Nov 2008 A1
20080281349 Becker Nov 2008 A2
20080287908 Muni et al. Nov 2008 A1
20080293999 Halahmi Nov 2008 A1
20080319424 Muni et al. Dec 2008 A1
20090005763 Makower et al. Jan 2009 A1
20090028923 Muni et al. Jan 2009 A1
20090030274 Goldfarb et al. Jan 2009 A1
20090054803 Saadat et al. Feb 2009 A1
20090076331 Konwitz et al. Mar 2009 A1
20090093823 Chang et al. Apr 2009 A1
20090125046 Becker May 2009 A1
20090156980 Eaton et al. Jun 2009 A1
20090163848 Morriss et al. Jun 2009 A1
20090163890 Clifford et al. Jun 2009 A1
20090171301 Becker Jul 2009 A1
20090181074 Makower et al. Jul 2009 A1
20090187098 Makower et al. Jul 2009 A1
20090198216 Muni et al. Aug 2009 A1
20090214466 Levin Aug 2009 A1
20090227900 Kim et al. Sep 2009 A1
20090240112 Goldfarb et al. Sep 2009 A1
20090240237 Goldfarb et al. Sep 2009 A1
20090304802 Djupesland et al. Dec 2009 A1
20090306588 Nguyen et al. Dec 2009 A1
20090312696 Copa et al. Dec 2009 A1
20090312745 Goldfarb et al. Dec 2009 A1
20090318797 Hadani Dec 2009 A1
20100010302 Hadani Jan 2010 A1
20100016844 Patel et al. Jan 2010 A1
20100030031 Goldfarb et al. Feb 2010 A1
20100030113 Morriss et al. Feb 2010 A1
20100030131 Morriss et al. Feb 2010 A1
20100030187 Xia Feb 2010 A1
20100030188 Xia Feb 2010 A1
20100035805 Hafner Feb 2010 A1
20100042046 Chang et al. Feb 2010 A1
20100056867 LaBombard et al. Mar 2010 A1
20100057048 Eldredge Mar 2010 A1
20100076269 Makower et al. Mar 2010 A1
20100081873 Tanimura et al. Apr 2010 A1
20100099946 Jenkins et al. Apr 2010 A1
20100100181 Makower et al. Apr 2010 A1
20100105983 Oneda et al. Apr 2010 A1
20100114066 Makower et al. May 2010 A1
20100114184 Degtyar et al. May 2010 A1
20100121308 Muni et al. May 2010 A1
20100152730 Makower et al. Jun 2010 A1
20100168511 Muni et al. Jul 2010 A1
20100174138 Chang et al. Jul 2010 A1
20100174196 Ryan et al. Jul 2010 A1
20100174308 Chang et al. Jul 2010 A1
20100179488 Spiegel et al. Jul 2010 A1
20100179511 Rajan et al. Jul 2010 A1
20100198135 Morriss et al. Aug 2010 A1
20100198191 Clifford et al. Aug 2010 A1
20100198247 Chang et al. Aug 2010 A1
20100210901 Makower et al. Aug 2010 A1
20100211005 Edwards et al. Aug 2010 A1
20100211007 Lesch et al. Aug 2010 A1
20100211140 Barbut et al. Aug 2010 A1
20100217296 Morriss et al. Aug 2010 A1
20100241068 Chen Sep 2010 A1
20100241155 Chang et al. Sep 2010 A1
20100256653 Kaplan et al. Oct 2010 A1
20100268245 Chang et al. Oct 2010 A1
20100274188 Chang et al. Oct 2010 A1
20100274222 Setliff et al. Oct 2010 A1
20100280626 Shalon et al. Nov 2010 A1
20100282246 Djupesland et al. Nov 2010 A1
20100286659 Terrill et al. Nov 2010 A1
20100292765 Etwil Nov 2010 A1
20100298640 Oneda et al. Nov 2010 A1
20100298862 Chang et al. Nov 2010 A1
20100305697 Clifford et al. Dec 2010 A1
20100324483 Rozenberg et al. Dec 2010 A1
20110004057 Goldfarb et al. Jan 2011 A1
20110004058 Oneda et al. Jan 2011 A1
20110004192 Eaton et al. Jan 2011 A1
20110004194 Eaton et al. Jan 2011 A1
20110015645 Liu et al. Jan 2011 A1
20110015734 Gonzales et al. Jan 2011 A1
20110020279 Shantha Jan 2011 A1
20110054395 O'Dea et al. Mar 2011 A1
20110060214 Makower Mar 2011 A1
20110087192 Uhland et al. Apr 2011 A1
20110098659 Covello Apr 2011 A1
20110112512 Muni et al. May 2011 A1
20110114087 Djupesland et al. May 2011 A1
20110152838 Xia Jun 2011 A1
20110160623 Shalev Jun 2011 A1
20110160740 Makower et al. Jun 2011 A1
20110208215 Modesitt et al. Aug 2011 A1
20110224652 Drontle et al. Sep 2011 A1
20110245765 Jacobsen et al. Oct 2011 A1
20110288559 Shahoian Nov 2011 A1
20110318345 Djupesland Dec 2011 A1
20120010646 Keith et al. Jan 2012 A1
20120017893 Xia Jan 2012 A1
20120046607 Syk Feb 2012 A1
20120053404 Schreck et al. Mar 2012 A1
20120071715 Beyar et al. Mar 2012 A1
20120071727 Hanson et al. Mar 2012 A1
20120071824 Chang et al. Mar 2012 A1
20120071856 Goldfarb et al. Mar 2012 A1
20120071857 Goldfarb et al. Mar 2012 A1
20120078118 Jenkins et al. Mar 2012 A1
20120078377 Gonzales et al. Mar 2012 A1
20120089028 Hadani et al. Apr 2012 A1
20120090620 Deutsch Apr 2012 A1
20120101343 Duffy et al. Apr 2012 A1
20120116254 Morriss May 2012 A1
20120128683 Shantha May 2012 A1
20120136207 Goldfarb et al. May 2012 A1
20120157968 Eldredge et al. Jun 2012 A1
20120172751 Levin Jul 2012 A1
20120172835 Becker Jul 2012 A1
20120184983 Chang et al. Jul 2012 A1
20120220923 Morriss et al. Aug 2012 A1
20120221034 Dinger et al. Aug 2012 A1
20120227457 Kim et al. Sep 2012 A1
20120245419 Makower et al. Sep 2012 A1
20120245456 Kim et al. Sep 2012 A1
20120259215 Gerrans et al. Oct 2012 A1
20120259216 Gerrans et al. Oct 2012 A1
20120265094 Goldfarb et al. Oct 2012 A1
20120277578 Gunday et al. Nov 2012 A1
20120302825 Schaeffer et al. Nov 2012 A1
20120310145 Clifford et al. Dec 2012 A1
20120323214 Shantha Dec 2012 A1
20130006055 Goldfarb et al. Jan 2013 A1
20130018431 Levin Jan 2013 A1
20130030458 Drontle et al. Jan 2013 A1
20130041463 Ressemann Feb 2013 A1
20130053644 Smith et al. Feb 2013 A1
20130053822 Fischell et al. Feb 2013 A1
20130053824 Seiden et al. Feb 2013 A1
20130066358 Nalluri et al. Mar 2013 A1
20130072958 Ressemann et al. Mar 2013 A1
20130073015 Rozenberg Mar 2013 A1
20130085472 Shaari Apr 2013 A1
20130090544 Clifford et al. Apr 2013 A1
20130096605 Becker Apr 2013 A1
20130103023 Monson et al. Apr 2013 A1
20130123833 Lesch et al. May 2013 A1
20130130145 Kaeding et al. May 2013 A1
20130158475 Xia et al. Jun 2013 A1
20130165873 Morriss et al. Jun 2013 A1
20130172852 Chang Jul 2013 A1
20130184532 Goldfarb et al. Jul 2013 A1
20130184568 Muni et al. Jul 2013 A1
20130184574 Newhauser et al. Jul 2013 A1
20130184683 Chow et al. Jul 2013 A1
20130190678 Andreas et al. Jul 2013 A1
20130197426 Morriss et al. Aug 2013 A1
20130231529 John et al. Sep 2013 A1
20130245608 Muni et al. Sep 2013 A1
20130245609 Schaeffer et al. Sep 2013 A1
20130261388 Jenkins et al. Oct 2013 A1
20130274600 Jenkins et al. Oct 2013 A1
20130274651 Barbut et al. Oct 2013 A1
20130274715 Chan et al. Oct 2013 A1
20130276794 Morriss Oct 2013 A1
20130281982 Makower et al. Oct 2013 A1
20130302445 Barbut et al. Nov 2013 A1
20130303968 Clifford et al. Nov 2013 A1
20130324970 Arcand et al. Dec 2013 A1
20130325052 Chang et al. Dec 2013 A1
20140012182 Shantha Jan 2014 A1
20140018775 Swords et al. Jan 2014 A1
20140030520 Nakamura et al. Jan 2014 A1
20140031726 Chernomorsky et al. Jan 2014 A1
20140031792 Darin et al. Jan 2014 A1
20140066901 Dinger et al. Mar 2014 A1
20140066928 Bennett et al. Mar 2014 A1
20140073858 Sherwinter Mar 2014 A1
20140074065 Muni et al. Mar 2014 A1
20140074140 Johnson et al. Mar 2014 A1
20140074141 Johnson et al. Mar 2014 A1
20140088498 Stevens et al. Mar 2014 A1
20140094733 Clopp et al. Apr 2014 A1
20140107404 Gruber Apr 2014 A1
20140107427 Chow et al. Apr 2014 A1
20140114233 Deem et al. Apr 2014 A1
20140135587 Hess May 2014 A1
20140144443 Djupesland et al. May 2014 A1
20140163072 Romon-de-Jesus Jun 2014 A1
20140180328 Vaccaro et al. Jun 2014 A1
20140200443 Chang et al. Jul 2014 A1
20140200444 Kim et al. Jul 2014 A1
20140213968 Vaccaro et al. Jul 2014 A1
20140218904 Cayton Aug 2014 A1
20140238398 Christopher et al. Aug 2014 A1
20140242064 Morriss et al. Aug 2014 A1
20140243792 Berman et al. Aug 2014 A1
20140243793 Morriss et al. Aug 2014 A1
20140243876 Suehara Aug 2014 A1
20140276624 Jeppson Sep 2014 A1
20140276626 Jenkins et al. Sep 2014 A1
20140276627 Jenkins et al. Sep 2014 A1
20140277072 Suehara Sep 2014 A1
20140288623 Levin Sep 2014 A1
20140295728 Cayton Oct 2014 A1
20140296898 Chang et al. Oct 2014 A1
20140324093 Chang et al. Oct 2014 A1
20140330074 Morriss et al. Nov 2014 A1
20140336575 Muni et al. Nov 2014 A1
20140336693 Goldfarb et al. Nov 2014 A1
20140336694 Becker Nov 2014 A1
20140350520 Drontle et al. Nov 2014 A1
20150038901 Lampropoulos et al. Feb 2015 A1
20150039014 Schaeffer et al. Feb 2015 A1
20150045825 Caplan et al. Feb 2015 A1
20150065872 Drake et al. Mar 2015 A1
20150065995 Sanchez et al. Mar 2015 A1
20150141819 Linden et al. May 2015 A1
20150141915 Lampropoulos et al. May 2015 A1
20150164309 Chandler et al. Jun 2015 A1
20150164571 Saadat Jun 2015 A1
20150173592 Leeflang et al. Jun 2015 A1
20150174406 Lamensdorf et al. Jun 2015 A1
20150196735 Olig et al. Jul 2015 A1
20150196753 Levin Jul 2015 A1
20150230700 Chandler et al. Sep 2015 A1
20150258315 Chandler et al. Sep 2015 A1
20150352341 Chandler et al. Dec 2015 A1
20160008017 Makower et al. Jan 2016 A1
20160135671 Chandler et al. May 2016 A1
20160271375 Chandler et al. Sep 2016 A1
20170246434 Chandler et al. Aug 2017 A1
20180042471 Chandler et al. Feb 2018 A1
20180333564 Chandler et al. Nov 2018 A1
20190091450 Chandler et al. Mar 2019 A1
Foreign Referenced Citations (23)
Number Date Country
2266958 Oct 1999 CA
2522386 Nov 2012 EP
2522586 Nov 2012 EP
1 988 953 Jul 2017 EP
2 397 025 Jul 2004 GB
2 397 243 Jul 2004 GB
2 402 886 Dec 2004 GB
2 403 154 Dec 2004 GB
2 404 867 Feb 2005 GB
2 405 350 Mar 2005 GB
2 405 800 Mar 2005 GB
2 414 414 Nov 2005 GB
20050117277 Dec 2005 KR
1020050117277 Apr 2006 KR
1020120013930 Feb 2012 KR
2002005703 Jan 2002 WO
2002007632 Jan 2002 WO
2006020180 Feb 2006 WO
2010078145 Jul 2010 WO
2012123819 Sep 2012 WO
2015095214 Jun 2015 WO
2015095214 Jun 2015 WO
WO-2016108055 Jul 2016 WO
Non-Patent Literature Citations (20)
Entry
Agro, et al., “Lightwand intubation using the Trachlight(TM): a brief review of current knowledge,” Canadian Journal of Anesthesia, (2000), pp. 592-599.
Borris, et al., “Intraoperative nasal transillumination for maxillary sinus augmentation procedures: A technical note,” International Journal of Oral and Maxillofacial Implants, vol. 13, Issue 4 (Jul.-Aug. 1998), pp. 569-570 (abstract only).
Friedman, et al., “Intraoperative and Postoperative Assessment of Frontal Sinus Patency by Transillumination,” The Laryngoscope, vol. 110 (Apr. 2000), pp. 683-684.
Hung, et al., “Lightwand intubation: II—Clinical trial of a new lightwand for tracheal intubation in patients with difficult airways,” Canadian Journal of Anaesthesia, vol. 42, Issue 9 (1995), pp. 826-830.
Massengill, “An Objective Technique for Submucous Cleft Palate Detection,” Plastic and Reconstructive Surgery, vol. 37, No. 4 (1966), pp. 355-359.
Miyazaki, et al., “Fiberscopic Methods for Assessment of Velopharyngeal Closure during Various Activities,” presented at the 15th annual convention of the Japan Society of Oral Surgery in Nagoya, Oct. 1970; presented at the 25th annual convention of the Japan Society of Oral Medicine in Tokyo, Apr. 1971; and presented at the 2nd International Cleft Palate Congress in Copenhagen, Aug. 1973.
U.S. Appl. No. 14/298,521 entitled Method of Performing a Sphenopalatine Ganglion—Block Procedure, filed Jun. 6, 2014.
U.S. Appl. No. 14/572,353 entitled Surgical Device for Performing a Sphenopalatine Ganglion Block Procedure, filed Dec. 16, 2014.
U.S. Appl. No. 14/712,722 entitled Method of Performing a Sphenopalatine Ganglion Block Procedure, filed May 14, 2015.
U.S. Appl. No. 15/008,115 entitled Method of Performing a Sphenopalatine Ganglion Block Procedure, filed Jan. 27, 2016.
U.S. Appl. No. 29/512,059 entitled Surgical Device, filed Dec. 16, 2014, 2015.
International Preliminary Report on Patentability for International Application No. PCT/US2014/070642 dated Apr. 9, 2015—12 pages.
International Search Report (ISR) for International Application No. PCT/US2014/070642 dated Apr. 9, 2015—3 pages.
Written Opinion of the International Searching Authority for International Application No. PCT/US2014/070642 dated Apr. 9, 2015—11 pages.
Cohen, et. al., “Transnasal Illumination to Guide the Craniofacial Resection of Anterior Skull Based Neoplasms,” Surgical Neurology, vol. 40 (1993), pp. 420-423.
Dolor, et. al., “Management of Rhinosinusitis in Adults: Clinical Applications of Recent Evidence and Treatment Recommendations,” Journal of Clinical Outcomes Management, vol. 9, No. 8 (Aug. 2002), pp. 463-476.
Felisati, “Headache & Migraine; Sphenopalatine endoscopic ganglion block alleviates cluster headache symptoms,” Life Science Weekly (Oct. 10, 2006), pp. 741.
Petroianu, et. al., “Intubation with Transillumination: Nasal or Oral?” Prehospital and Disaster Medicine, vol. 14, No. 2 (Apr.-Jun. 1999), pp. 72-73.
WelchAllyn Pocketscopes, Operating Instruction Manual, circa 2000.
WelchAllyn 3.5v Transilluminators product brochure, circa 2000.
Provisional Applications (3)
Number Date Country
62691010 Jun 2018 US
62782889 Dec 2018 US
62782898 Dec 2018 US